Sudbury, MA, United States of America

Jason Woertink

USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Jason Woertink**

Introduction

Jason Woertink, an accomplished inventor based in Sudbury, Massachusetts, has made significant contributions to the field of pharmaceuticals. With a keen focus on solid forms of potent compounds, he holds a patent that showcases his innovative approach to drug formulation.

Latest Patents

Jason Woertink is the inventor of a patent titled "Solid forms of ceftolozane." This patent describes novel solid forms of ceftolozane, along with methods for their preparation and use. The advancements provided by these solid forms could potentially enhance the efficacy and delivery of this important antibiotic, offering new opportunities in medical treatment.

Career Highlights

Currently, Jason is employed at Calixa Therapeutics, Inc., where he applies his expertise to further the development of therapeutic innovations. His work at Calixa Therapeutics signifies his commitment to advancing healthcare solutions, particularly in combating multidrug-resistant infections.

Collaborations

Throughout his professional journey, Jason has collaborated with notable colleagues, including You Seok Hwang and Nicole Miller Damour. These collaborative efforts reflect a shared mission to push the boundaries of pharmaceutical research and development.

Conclusion

Jason Woertink exemplifies the spirit of innovation within the pharmaceutical industry. His contributions, particularly through his patent on solid forms of ceftolozane, illustrate how dedicated inventors can impact healthcare. As he continues his work at Calixa Therapeutics, the future holds promise for further breakthroughs guided by his expertise and collaborative efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…